Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized …

O Manuel, M Laager, C Hirzel… - Clinical Infectious …, 2024 - academic.oup.com
Background The use of assays detecting cytomegalovirus (CMV)–specific T cell–mediated
immunity may individualize the duration of antiviral prophylaxis after transplantation …
被引用次数：6 相关文章

Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized …

O Manuel, M Laager, C Hirzel, D Neofytos… - … Diseases: an Official …, 2024 - europepmc.org
Background The use of assays detecting cytomegalovirus (CMV)-specific T cell-mediated
immunity may individualize the duration of antiviral prophylaxis after transplantation …

Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical …

O Manuel, M Laager, C Hirzel, D Neofytos… - Clinical infectious …, 2023 - boris.unibe.ch
BACKGROUND The use of assays detecting cytomegalovirus (CMV)-specific T-cell-
mediated immunity may individualize the duration of antiviral prophylaxis in transplant …

Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical …

O Manuel, M Laager, C Hirzel, D Neofytos… - Clinical Infectious …, 2023 - zora.uzh.ch
BACKGROUND: The use of assays detecting cytomegalovirus (CMV)-specific T-cell-
mediated immunity may individualize the duration of antiviral prophylaxis in transplant …

Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized …

O Manuel, M Laager, C Hirzel… - Clinical Infectious …, 2024 - academic.oup.com
Background The use of assays detecting cytomegalovirus (CMV)–specific T cell–mediated
immunity may individualize the duration of antiviral prophylaxis after transplantation …
[HTML] nih.gov

[HTML][HTML] Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter …

O Manuel, M Laager, C Hirzel, D Neofytos… - … Diseases: An Official …, 2024 - ncbi.nlm.nih.gov
Background The use of assays detecting cytomegalovirus (CMV)–specific T cell–mediated
immunity may individualize the duration of antiviral prophylaxis after transplantation …

Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized …

O Manuel, M Laager, C Hirzel, D Neofytos, LN Walti… - 2024 - pubmed.ncbi.nlm.nih.gov
Background The use of assays detecting cytomegalovirus (CMV)-specific T cell-mediated
immunity may individualize the duration of antiviral prophylaxis after transplantation …

Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical …

O Manuel, M Laager, C Hirzel, D Neofytos… - … Diseases: an Official …, 2023 - europepmc.org
The use of assays detecting cytomegalovirus (CMV)-specific T-cell-mediated immunity may
individualize the duration of antiviral prophylaxis in transplant recipients. In this open-label …